⌘K

Login Start Free

Home/Filings/4/0001190938-16-000001

4//SEC Filing

Immune Therapeutics, Inc. 4

Accession 0001190938-16-000001

CIK 0001559356operating

View on SEC.gov Company Profile

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 3:37 PM ET

Size

5.2 KB

Accession

0001190938-16-000001

Insider Transaction Report

Form 4

Period: 2016-06-30

Immune Therapeutics, Inc.IMUN

CHIEF FINANCIAL OFFICER

Transactions

Award
Warrant for Common Stock
2016-06-30+100,000→ 425,000 total
Exercise: $0.17From: 2016-06-30Exp: 2021-06-29→ Common Stock (100,000 underlying)

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Immune Therapeutics, Inc.

CIK 0001559356

Entity typeoperating

IncorporatedFL

Related Parties

1

filerCIK 0001559356

Filing Metadata

Form type: 4
Filed: Jul 5, 8:00 PM ET
Accepted: Jul 6, 3:37 PM ET
Size: 5.2 KB

View on SEC.gov